雷公藤多苷片联合肾复康胶囊治疗慢性肾小球肾炎的临床效果分析  

Clinical effect analysis of tripterygium glycoside tablets combined with Shenfukang capsules in treating chronic glomerulonephritis

作　　者：王丽 WANG Li(Panjin Central Hospital,Panjin 124000,China)

机构地区：[1]盘锦市中心医院,124000

出　　处：《中国现代药物应用》2022年第20期135-137,共3页Chinese Journal of Modern Drug Application

摘　　要：目的观察雷公藤多苷片联合肾复康胶囊对慢性肾小球肾炎的治疗效果。方法62例慢性肾小球肾炎患者,通过随机自愿原则分为观察组和对照组,各31例。对照组应用雷公藤多苷片治疗,观察组应用雷公藤多苷片+肾复康胶囊治疗。比较两组治疗效果及用药不良反应发生情况。结果观察组的治疗总有效率为87.10%,明显高于对照组的64.52%,差异有统计学意义(P<0.05)。观察组的用药不良反应发生率为9.68%,与对照组的6.45%比较,差异无统计学意义(P>0.05)。结论临床通过雷公藤多苷片联合肾复康胶囊对慢性肾小球肾炎进行治疗,可有效提升临床治疗疗效,不会产生严重的不良反应,值得推荐。Objective To observe the therapeutic effect of tripterygium glycoside tablets combined with Shenfukang capsules in treating chronic glomerulonephritis.Methods A total of 62 patients with chronic glomerulonephritis were randomly divided into observation group and control group,with 31 cases in each group.The control group was treated with tripterygium glycoside tablets,and the observation group was treated with tripterygium glycoside tablets+Shenfukang capsules.The therapeutic effect and the occurrence of adverse drug reactions were compared between the two groups.Results The total effective rate of treatment of the observation group was 87.10%,which was significantly higher than 64.52%of the control group,and the difference was statistically significant(P<0.05).The incidence of adverse drug reactions in the observation group was 9.68%,and the difference was not statistically significant compared with 6.45%in the control group(P>0.05).Conclusion The clinical treatment of chronic glomerulonephritis with tripterygium glycoside tablets combined with Shenkangfu capsule can effectively improve the clinical therapeutic effect without serious adverse reactions.It is worth recommending.

关 键 词：雷公藤多苷片 肾康复胶囊 慢性肾小球肾炎 疗效 不良反应 

分 类 号：R277.5[医药卫生—中医学]